Chimeric antigen receptor (CAR) T cell therapy has been an amazing advance for treating blood cancers like leukemia, lymphoma and multiple myeloma. Now, it is showing promise for solid tumors — from lung cancer to kidney cancer to bone cancer — as well. “We’re trying to adopt the same strategy that has worked in hematologic malignancies, where CAR T cell treatments have greatly increased survival,” says Samer Srour, MB ChB, assistant...